Residents of all Russian regions and foreigners can join COVID-19 vaccine trial
Now residents do not have to have a Moscow mandatory medical insurance policy to take part in the coronavirus vaccine post-approval trial. Trial participants from Russian regions and foreign citizens working or living in Moscow can get the jab.
“Moscow is a metropolitan area which is also home to people from Russian regions and citizens of foreign countries who study, work and live here. Now everyone is welcome to participate in the COVID-19 vaccine post-approval trial at Moscow medical facilities, and it is not necessary to have a Moscow mandatory medical insurance policy. This will significantly expand the circle of people who can get the vaccine within the trial. It is important for participants to stay in Moscow, so as not to interrupt medical observation,” said Deputy Mayor for Social Development Anastasia Rakova.
The Government of Moscow and the Gamaleya Research Institute of Epidemiology and Microbiology at the Ministry of Healthcare welcome everyone to take part in the COVID-19 vaccine post-approval clinical trial. Vaccination is free. The vaccine is already being tested at 16 Moscow medical facilities.
Adult citizens of Russia or other countries can participate if they speak Russian well enough to fill in documents and communicate with doctors. In addition, they must not be ill with ARVI or COVID-19 and must not have been in contact with COVID-19 patients within two weeks of testing and at the time of vaccination. The jab is contraindicated for pregnant women and families planning to conceive in the next three months.
Medical staff will be in close contact with volunteers by phone, through a special mobile app or via telemedicine technology. Volunteers feeling unwell after vaccination should tell their doctor.
Applications to take part in the COVID-19 vaccine post-approval clinical trial are accepted on the mos.ru portal.